Use of Recombinant Human Parathyroid Hormone to Treat Hungry Bone Syndrome in Hemodialysis Patient

Use of Recombinant Human Parathyroid Hormone to Treat Hungry Bone Syndrome in Hemodialysis Patient

We report the case of a 35-year-old female with end-stage renal disease on hemodialysis for nine years. She was diagnosed with secondary hyperparathyroidism complicated with a brown tumor in the mandible. After medical therapy failed, she underwent total parathyroidectomy (PTX), which was complicate...

Full description

Bibliographic Details
Main Authors: Chaaban Ahmed, Fatima Kendi, Nicole Gebran, Clarisse Barcebal, Khalid Dahmani, Ali El Houni, Mohammad Budruddin
Format: Article
Language:English
Published: Oman Medical Specialty Board 2020-07-01
Series:Oman Medical Journal
Subjects:
parathyroidectomy
hypocalcemia
teriparatide
vitamin d
hyperparathyroidism
secondary
parathyroid hormone
kidney failure
chronic
renal dialysis
bone diseases
lupus erythematosus
systemic
Online Access:http://omjournal.org/articleDetails.aspx?coType=1&aId=2718

Internet

http://omjournal.org/articleDetails.aspx?coType=1&aId=2718

Similar Items